BTP: Simplifying the Deployment and Management of Enterprise Blockchain Infrastructure

Jul 2021

We are excited to back BTP’s enterprise blockchain experts on their mission to bring the benefits of distributed ledgers to businesses.

Unchained Capital Raises $25M Series A

Jun 2021

Our portfolio company Unchained has closed a $25M Series A, bringing its company valuation to $125M.

Finoa Closes $22M Series A

Apr 2021

We are thrilled to announce that we continue to back our portfolio company Finoa as part of their Series A round led by Balderton Capital.

Celestia: The General-Purpose Data Availability Layer of the Decentralized Internet

Mar 2021

Read our Investment Thesis on why Celestia and its general-purpose data availability layer is a paradigm shift for scalable Blockchain architecture and a catalyst towards a decentralized Internet.

Celestia Closes $1.5M Seed Round

Mar 2021

We are thrilled to be a major part of the $1.5M seed round of Celestia alongside Binance Labs, Maven11 and KR1.

Unchained Capital Raises $5.5M Seed Round

Mar 2021

Unchained Capital raised a $5.5 million equity seed round led by institutional Bitcoin technology and financial services firm NYDIG.

Unchained Capital: Unlocking the Potential of Bitcoin-Native Multisignature Capabilities

Dec 2020

Unchained Capital provides financial services on top of its highly secure and innovative collaborative custody infrastructure tailored to the needs of long-term Bitcoin holders.

Notabene Raises Seed Round of $1.77M

Nov 2020

As Notabene's first institutional investor in their pre-Seed stage, we are happy to be accompanied by well-known names from the Blockchain and FinTech space: our network partners at Castle Island Ventures led the Seed round, joined by Green Visor Capital, among others.

Notabene: Embracing Regulation within the Blockchain Space

Nov 2020

Notabene is building a Blockchain-focused compliance platform to provide crypto businesses with the tools to implement regulatory compliance in a simple way. Their diverse founder team follows a Blockchain-first approach combining decentralized-identity technology with the highest compliance standards.

Molecule: The Next Stage in the Evolution of Drug Development

Jul 2020

Molecule aims to disrupt the pharmaceutical drug discovery and development industry. Their outstanding team is building a trust-less open platform for the efficient management of pharmaceutical intellectual property (IP) between researchers and investors.

We Are Backing Finoa

Jan 2020

Happy to announce that Signature Ventures joined the seed round of Finoa GmbH. Looking forward to supporting Christopher May and Henrik Gebbing in building the leading custody solution for digital assets in Europe.